Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis
Clinical trial NCT04132960 · COMPLETED
Trial details
- NCT number
- NCT04132960
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-21
- Primary completion
- 2021-10-29
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.